Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in infants with refractory partial-onset seizures
NCT00113815Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- May 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 23
01
Overview
Phase 3, randomised, double-blind trial of topiramate in focal onset seizure (4 arms), sponsored by Johnson & Johnson. Primary endpoint: Video-recorded EEG at Day 20. Started May 2005; status: completed.
02
Drugs
topiramate
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00113815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113815.